<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>GBIHealth | wechat-feeds</title><link>http://MzA5Njc0MTAxOQ.favicon.privacyhide.com/favicon.ico</link><description>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 08 Feb 2021 11:23:01 +0800</pubDate><image><url>http://MzA5Njc0MTAxOQ.favicon.privacyhide.com/favicon.ico</url><title>GBIHealth | wechat-feeds</title><link>http://MzA5Njc0MTAxOQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>财报解析 | 罗氏2020年中国业绩喜忧参半：制药业务增长8%，诊断下降11%</title><link>https://mp.weixin.qq.com/s/vkhBkpEEvecedTneb_EGFg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6Mf59MgnPicLkH4u5KIEaeriauMNnqX14UuDb87eRcRQgHdQQIwpvibfKKpmRWmB03npOAcCjjfSyxmA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>​瑞士制药公司罗氏（NTSE.ROC）公布了2020年财务业绩]]></content:encoded><pubDate>Sun, 07 Feb 2021 20:17:51 +0800</pubDate></item><item><title>天境生物CD73抗体Uliledlimab在中美取得多项临床进展；三生制药与阿斯利康终止百达扬许可，继续合作百泌达</title><link>https://mp.weixin.qq.com/s/0_SgrVgYJH1eZyXDPhMA-Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Sun, 07 Feb 2021 20:17:51 +0800</pubDate></item><item><title>DEVINT | 东方启音获C1轮2300万美金融资</title><link>https://mp.weixin.qq.com/s/i2l_l2fZ69plC8K-qMVy1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6O5msprT9YicB9bhj2QQ5t82cby86Oiah0un5Mz25clLTjbxT7bmZJw9qv1j8wmzcTgTu5ibnASiaJib0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内领先的儿童言语康复与自闭症干预机构东方启音宣布完成C1轮2300万美金融资]]></content:encoded><pubDate>Sun, 07 Feb 2021 20:17:51 +0800</pubDate></item><item><title>期刊杂志 |《中国药刊》第6期：乐城先行区模式介绍；2020年许可交易纵览；医药圈融资、并购、IPO近况……</title><link>https://mp.weixin.qq.com/s/DCq_Qy3WsB21MIR3aXIuig</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6MGEzaALJiaYWFmA9XmtL7WYy69Gk5orQelIe3LW5Rq6PtfBHySO68h5frON04iajSLzUliaoLM9M5qw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>干货满满]]></content:encoded><pubDate>Sat, 06 Feb 2021 23:27:48 +0800</pubDate></item><item><title>先声药业因垄断被罚1亿元；安斯泰来吉瑞替尼附条件获批；阿斯利康与普瑞基准达成合作</title><link>https://mp.weixin.qq.com/s/qRoq826iSwvOgccXPJZ3dw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Sat, 06 Feb 2021 23:27:48 +0800</pubDate></item><item><title>DEVINT | 微远基因获2亿元C轮融资, 腾讯领投；万乘基因完成数千万人民币Pre-A轮融资</title><link>https://mp.weixin.qq.com/s/A3GqeSh0t0RGPS_dwzxARA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6O5msprT9YicB9bhj2QQ5t82cby86Oiah0un5Mz25clLTjbxT7bmZJw9qv1j8wmzcTgTu5ibnASiaJib0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>微远基因专注于基因技术创新与感染精准医疗]]></content:encoded><pubDate>Sat, 06 Feb 2021 23:27:48 +0800</pubDate></item><item><title>第四批国采拟中选结果：平均降幅68.39%，外企仅5家中标，内资5家企业中标产品最多（内含Excel表单）</title><link>https://mp.weixin.qq.com/s/OEsWM_tCluqkyXTJSCIZhQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NQH2xPevqRmibibe9ibicVLiaMFJF7YUcVqZIOrGvPFyfYgLcpVKGoU7azxj8JH0QQxTnt4weU8yeicL9g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>拟中选结果于2月4~7日公示]]></content:encoded><pubDate>Thu, 04 Feb 2021 21:07:29 +0800</pubDate></item><item><title>诺和诺德2020年中国增长11%；拜耳前列腺癌治疗药、阿斯利康安达唐新适应证在华获批</title><link>https://mp.weixin.qq.com/s/mIUU1yJjWAbKIUN3IfnQTw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Thu, 04 Feb 2021 21:07:29 +0800</pubDate></item><item><title>DEVINT | 美的集团23亿元接管万东医疗，正式踏足医械领域</title><link>https://mp.weixin.qq.com/s/DIOTDbA1gSpiIAMA_olUWg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6O5msprT9YicB9bhj2QQ5t82cby86Oiah0un5Mz25clLTjbxT7bmZJw9qv1j8wmzcTgTu5ibnASiaJib0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>美的集团此前已有意布局医疗业务]]></content:encoded><pubDate>Thu, 04 Feb 2021 21:07:29 +0800</pubDate></item><item><title>财报解析 | 礼来2020年Q4中国收入增长31%；达伯舒全年同比增长76.7%！</title><link>https://mp.weixin.qq.com/s/r5DQ77p_ibyBm4fpAJUxqw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6Mf59MgnPicLkH4u5KIEaeriauMNnqX14UuDb87eRcRQgHdQQIwpvibfKKpmRWmB03npOAcCjjfSyxmA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>唯择于2020年12月在中国上市，预计2021年将实现更快的增长。]]></content:encoded><pubDate>Wed, 03 Feb 2021 18:18:32 +0800</pubDate></item><item><title>安进PDE4抑制剂在华申报上市；拜耳创新疗法上市申请获受理；信达生物达伯舒获批新适应证</title><link>https://mp.weixin.qq.com/s/1yFIM0LY2mvp-xGP4IlYwg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Wed, 03 Feb 2021 18:18:32 +0800</pubDate></item><item><title>DEVINT | 花沐医疗获得近亿元B轮融资；Exegenesis Bio获数千万美元B+轮融资</title><link>https://mp.weixin.qq.com/s/5NedIqqKz2EOK_LGy4dmKA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6O5msprT9YicB9bhj2QQ5t82cby86Oiah0un5Mz25clLTjbxT7bmZJw9qv1j8wmzcTgTu5ibnASiaJib0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>推动可降解生物材料替代传统植入物]]></content:encoded><pubDate>Wed, 03 Feb 2021 18:18:32 +0800</pubDate></item><item><title>第四批国采面面观：诺华、BI佛系参赛；认真如费卡最低价中标；华海、四环……开心过年</title><link>https://mp.weixin.qq.com/s/QmfI9cnd-YQZLtM_ZM0-_A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6Mf59MgnPicLkH4u5KIEaeria5OkwaOVeaoBHFf9MRZAawaIM4rqUvl7R5kKhXBIOibsIpibCR2FTuQWA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>进入查看更多报价、中标信息……]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:00:03 +0800</pubDate></item><item><title>11.1亿美元！君实生物实现PD-1在美国和加拿大的对外授权；康哲药业收购皮肤管线专业公司；正大天晴安罗替尼第四个适应证获批</title><link>https://mp.weixin.qq.com/s/wcAYger2ZpMCB3Gsyx2a_g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:00:03 +0800</pubDate></item><item><title>DEVINT | 迈步机器人获数千万元A+轮融资；诺博医疗获得数亿元B轮融资</title><link>https://mp.weixin.qq.com/s/4AMndDzaYcDAZqTYaugOow</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6O5msprT9YicB9bhj2QQ5t82cby86Oiah0un5Mz25clLTjbxT7bmZJw9qv1j8wmzcTgTu5ibnASiaJib0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>距2020年8月完成数千万元A轮融资仅5个月]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:00:03 +0800</pubDate></item><item><title>她曾负责奥贝胆酸开发，现被任命为一国内生物技术公司首席开发官</title><link>https://mp.weixin.qq.com/s/Bbb2zjqQ7ayPGE0erKz2DQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6OicQ38FIqHs9ISs6zP3ia7mBLGJ3vY0ic1I8ek94O3QFiaiciaKLiaSZWG8aT3ySkQjsMeqnrpfuCeH2xVQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>此前还曾担任BMS糖尿病产品组合的临床主管]]></content:encoded><pubDate>Mon, 01 Feb 2021 20:19:03 +0800</pubDate></item><item><title>安斯泰来白血病新药在中国获批；绿叶制药引入高瓴资战略投资；诺诚健华奥布替尼纳入六地商保目录</title><link>https://mp.weixin.qq.com/s/AY31QKON8drYQ8faFNSEGA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Mon, 01 Feb 2021 20:19:03 +0800</pubDate></item><item><title>DEVINT | 启明医疗引进澳洲Endoluminal瓣膜主动防周漏技术；图湃医疗获近1.5亿元A轮融资</title><link>https://mp.weixin.qq.com/s/lSZlXqdzRs0Rua5OQaTPSA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6O5msprT9YicB9bhj2QQ5t82cby86Oiah0un5Mz25clLTjbxT7bmZJw9qv1j8wmzcTgTu5ibnASiaJib0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>将其瓣膜主动防周漏技术引入中国，并全面应用于其新一代瓣膜产品上。]]></content:encoded><pubDate>Mon, 01 Feb 2021 20:19:03 +0800</pubDate></item><item><title>拜耳1类新药在华获批临床试验；百济神州在科创板递交IPO申请；李氏大药厂、基石药业抗PD-L1单抗拟纳入突破性治疗品种</title><link>https://mp.weixin.qq.com/s/1XbAowuhAgu0E4gsH8SQnQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6NlNjpM8fKyAtkTKO45HADHXvhTmzqFhmZY3YKfzX3OZDavNu3qzFXib50yLqOFZNeSicIN3cibFuXXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击蓝字关注我们，每天早上8点准时查收药讯早餐]]></content:encoded><pubDate>Sun, 31 Jan 2021 20:04:43 +0800</pubDate></item><item><title>DEVINT | 西门子NT-proBNP心衰检测试剂在华获批；瑞德医疗与Myomo成立合资公司，布局医疗外骨骼机器人</title><link>https://mp.weixin.qq.com/s/zKTIs9xnaifUBrAM9M4EJw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/JFBJaCrcf6O5msprT9YicB9bhj2QQ5t82cby86Oiah0un5Mz25clLTjbxT7bmZJw9qv1j8wmzcTgTu5ibnASiaJib0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>业内首家可以在一个化学发光检测平台上同时提供BNP和NT-proBNP检测的公司。]]></content:encoded><pubDate>Sun, 31 Jan 2021 20:04:43 +0800</pubDate></item></channel></rss>